Patents Examined by George Manuel
  • Patent number: 12083343
    Abstract: A system is disclosed in one example which allows for modelling the wellness of a given Implantable Pulse Generator (IPG) patient. The modelling, embodied in an algorithm, uses one or more qualitative measurements and one or more quantitative measurements taken from the patient. The algorithm correlates the qualitative measurements to the various quantitative measurements to eventually, over time, learn which quantitative measurements best correlate to the qualitative measurements provided by the patient. The algorithm can then using current quantitative measurements predict a wellness factor or score for the patient, which is preferably weighted to favor the quantitative measurements that best correlate to that patient's qualitative assessment of therapy effectiveness. Additionally, the wellness factor may be used to adjust the stimulation program that the IPG device provides to the patient.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: September 10, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Michael A. Moffitt
  • Patent number: 12082941
    Abstract: The present disclosure is directed to methods and apparatus for monitoring bone characteristics for various conditions such as osteoporosis and/or periodontitis. In various embodiments, a dental hygiene appliance (100) may include: a handle (102) adapted to be held by a user; a tool (106) secured to the handle to perform a dental hygiene-related task; emitter(s) (114A, 116, 360A) mounted on the dental hygiene appliance to emit wave(s) (252, 362) towards a mandible (250, 350) of the user; sensor(s) (114B, 116, 360B) mounted on the dental hygiene appliance to detect wave(s) (254, 364) propagating away from the mandible, wherein the detected wave(s) originate from or are caused by the emitted wave(s); and a controller (108) communicatively coupled with the emitter(s) and the sensor(s). The controller may: receive, from the sensor(s), signal(s) indicative of the detected waves; and determine, based on the signal(s), bone characteristic(s) of the user.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: September 10, 2024
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventor: Joep Van Berkel
  • Patent number: 12070278
    Abstract: A method for determining position of an electrode lead inside a body tissue, including: receiving electrical signals recorded from at least one macro electrode contact of an electrode lead positioned inside a body tissue; extracting spiking (SPK) signals from the received electrical signals; providing stored measurements or indications thereof; determining a position of the lead and/or the at least one macro electrode contact inside said body tissue based on the extracted SPK signals and the provided stored measurements or indications thereof.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: August 27, 2024
    Assignee: Alpha Omega Engineering Ltd.
    Inventors: Hagai Bergman, Salam Aukal
  • Patent number: 12070598
    Abstract: This document discusses, among other things, systems and methods for programming neuromodulation therapy to treat neurological or cardiovascular diseases. A system includes an input circuit that receives a modulation magnitude representing a level of stimulation intensity, a memory that stores a plurality of gain functions associated with a plurality of modulation parameters, and a electrostimulator that may generate and deliver an electrostimulation therapy. A controller may program the electrostimulator with the plurality of modulation parameters based on the received modulation magnitude and the plurality of gain functions, and control the electrostimulator to generate electrostimulation therapy according to the plurality of modulation parameters.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: August 27, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Goran N. Marnfeldt, Michael A. Moffitt
  • Patent number: 12070596
    Abstract: An apparatus, such as an implantable medical device, including an implantable device configured to cause trauma in an inner ear and/or a middle ear recipient. In an exemplary embodiment, the implantable device is a cochlear implant. In an exemplary embodiment, the implantable device is configured to deliver a therapeutic substance to body tissue of the recipient.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: August 27, 2024
    Assignee: Cochlear Limited
    Inventor: Daniel Smyth
  • Patent number: 12070606
    Abstract: A neuromodulation system comprises a plurality of electrical terminals configured for being respectively coupled to a plurality of electrodes, a user interface configured for receiving input from a user that selects one of a plurality of different shapes of a modulating signal and/or selects one of a plurality of different electrical pulse parameters of an electrical pulse train, neuromodulation output circuitry configured for outputting an electrical pulse train to the plurality of electrical terminals, and pulse train modulation circuitry configured for modulating the electrical pulse train in accordance with the selected shape of the modulating signal and/or selected electrical pulse parameter of the electrical pulse train.
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: August 27, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Changfang Zhu
  • Patent number: 12070604
    Abstract: This disclosure relates to implantable neuromodulation systems and methods, and in particular to systems and methods for sensing blood-based parameter changes triggered by neural stimulation and subsequently optimizing the stimulation parameters based on feedback from the sensed blood-based parameter changes. Embodiments are directed to a method that includes delivering neural stimulation to a nerve or artery/nerve plexus based on a first set of stimulation parameters, monitoring a response to the neural stimulation that includes monitoring responses of the nerve or artery/nerve plexus and blood-based parameters of the artery, modifying the first set of the stimulation parameters based on the blood-based parameters to create a second set of stimulation parameters, and delivering the neural stimulation based on the second set of the stimulation parameters.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: August 27, 2024
    Assignee: GALVANI BIOELECTRONICS LIMITED
    Inventors: Brian Pepin, Shiv Sabesan
  • Patent number: 12064282
    Abstract: Embodiments of the present disclosure relate to determining an optimal location on the body of a person where heart sounds may be optimally heard. The optimal location may be determined at a time prior to the attempted auscultation and ECG data corresponding to the optimal location may be stored in a memory of an auscultation device. Subsequently, when a e.g., physician wishes to listen to the heart sounds of the person, the physician may place the auscultation device at a first location on the patient. The auscultation device may periodically perform an ECG at a current location and use the ECG data at the current location and the ECG data at the optimal location to determine and provide guidance to the physician regarding a direction in which the auscultation device should be moved in order to reach the optimal location.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: August 20, 2024
    Assignee: ALIVECOR, INC.
    Inventors: Sean Cohen, Ahmad N. Saleh
  • Patent number: 12062425
    Abstract: A computer-implemented method is disclosed. The method includes determining a maximum target heart rate for a user using an electromechanical machine to perform a treatment plan, wherein the electromechanical machine is configured to be manipulated by the user while the user is performing the treatment plan. The method includes receiving, via an interface, an input pertaining to a perceived exertion level of the user, wherein the interface comprises a display configured to present information pertaining to the treatment plan. Based on the perceived exertion level and the maximum target heart rate, the method includes determining an amount of resistance for the electromechanical machine to provide via one or more pedals physically or communicatively coupled to the electromechanical machine. While the user performs the treatment plan, the method includes causing the electromechanical machine to provide the amount of resistance.
    Type: Grant
    Filed: July 31, 2023
    Date of Patent: August 13, 2024
    Assignee: ROM Technologies, Inc.
    Inventors: Joel Rosenberg, Steven Mason
  • Patent number: 12059256
    Abstract: [Problem] To provide an information processing system, an information processing method, and a recording medium that can detect a worry and notify a user of a message. [Solution] An information processing system includes a control unit that performs control to estimate at least one of a worry cause of the user and a degree of worry of the user, and present a message to the user when at least one of the worry cause and the degree of worry satisfies a specific condition.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: August 13, 2024
    Assignee: SONY CORPORATION
    Inventor: Hiroshi Iwanami
  • Patent number: 12053227
    Abstract: A device is described for treating a nasal airway by modifying a property of a nasal tissue of or near a nasal valve of the airway, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in the nasal airway. Various embodiments include an elongate shaft, a bipolar radiofrequency delivery member extending from one end of the shaft, and a handle attached to the elongate shaft at an opposite end from the radiofrequency delivery member. The radiofrequency delivery member is sized to be inserted into a nose and configured to at least temporarily deform the nasal tissue and deliver radiofrequency energy. The radiofrequency delivery member includes two rows of protruding electrodes disposed on a tissue contact surface, and the device is configured to deliver radiofrequency energy from one row of electrodes to the other row of electrodes.
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: August 6, 2024
    Assignee: Aerin Medical Inc.
    Inventors: Scott J. Wolf, Andrew Frazier
  • Patent number: 12048556
    Abstract: A method and system for determining rehabilitation treatment of a joint, the method comprising communicatively connecting to a plurality of sensors attached to an individual at muscles in a joint area, wherein the plurality of sensors transmit electrical signals generated by the muscle to the computing device. The method further comprising receiving the electrical signals from the plurality of sensors, generating initial measurement data by evaluating strength and activity level of the muscles based on the electrical signals, and comparing the initial measurement data with reference data, wherein the reference data includes measurements of healthy people with normal muscle function. The method further comprising generating a training plan based on the comparison.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: July 30, 2024
    Assignee: InBOS GmbH
    Inventor: Thomas Paszicsnyek
  • Patent number: 12048561
    Abstract: The wearable article (200) comprises a sensing component. The electronics module (100) is removably coupled to the wearable article (200). The electronics module comprises a housing and a processor disposed within the housing (101). An interface element (121, 123) interfaces with the sensing component so as to receive signals from the sensing component and provide the same to the processor. A sensor (105) is disposed within the housing (101). The sensor (105) monitors a property of the environment external the electronics module (100) through the housing (101). The housing (101) is constructed such that the sensor (105) has line of sight through the housing (101).
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: July 30, 2024
    Assignee: Prevayl Innovations Limited
    Inventor: Michael John Lynch
  • Patent number: 12021329
    Abstract: An implantable blood pump system is disclosed herein. The implantable blood pump system includes an implantable blood pump, a controller coupled to the blood pump, a connector receptacle, and a connector insert. The connector receptacle can include a plurality of contacts, and a following surface. The connector insert can be received within the connector receptacle to couple a plurality of insert contacts with the plurality of contacts of the connector receptacle. The connector insert can include walls defining a follower receptacle that can receive a portion of the following surface when the connector insert is in a desired alignment with respect to the connector receptacle, and a cam surface that can engage with the following surface to bias the connector insert to the desired alignment with respect to the connector receptacle when the connector insert is inserted into the connector receptacle.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: June 25, 2024
    Assignee: TC1 LLC
    Inventors: John Mark Di Paola, Michael McCoy, John Duc Nguyen, Jaime Romero, Dustin Roelle, Andrew Wong, Dmitry Protsenko, Michael Sahines
  • Patent number: 12011608
    Abstract: A cardiac medical system, such as an implantable cardioverter defibrillator (ICD) system, receives a cardiac electrical signal by and senses cardiac events when the signal crosses an R-wave sensing threshold. The system determines at least one sensed event parameter from the cardiac electrical signal for consecutive cardiac events sensed by the sensing circuit and compares the sensed event parameters to P-wave oversensing criteria. The system detects P-wave oversensing in response to the sensed event parameters meeting the P-wave oversensing criteria; and adjusts at least one of an R-wave sensing control parameter or a therapy delivery control parameter in response to detecting the P-wave oversensing.
    Type: Grant
    Filed: September 11, 2021
    Date of Patent: June 18, 2024
    Assignee: Medtronic, Inc.
    Inventors: Xusheng Zhang, Paul J. Degroot
  • Patent number: 12004714
    Abstract: A medical instrument includes an insertion section main body extending along a longitudinal axis, a rotation supporter attached to the insertion section main body, a power transmission member rotatably supported by the rotation supporter and having a blade to which a fluid is supplied, external teeth arranged on an outer circumferential surface of the power transmission member in a circumferential direction, a tubular rotation member disposed outside the power transmission member in a radial direction, internal teeth arranged on an inner circumferential surface of the rotation member in the circumferential direction, and a fluid duct configured to supply the fluid to the blade. The power transmission member is configured to rotate by receiving power generated in the blade due to supply of the fluid. The rotation member is configured to rotate about the longitudinal axis by receiving the power from the power transmission member as the internal teeth are meshed with the external teeth.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: June 11, 2024
    Assignee: OLYMPUS CORPORATION
    Inventor: Yuto Maekawa
  • Patent number: 12004796
    Abstract: A cryoablation method, system, and device that allows for real-time and accurate assessment and monitoring of PV occlusion and lesion formation without the need for expensive imaging systems and without patient exposure to radiation. The system includes a cryoballoon catheter with a cryoballoon, a distal electrode, a proximal electrode, and a temperature sensor. Impedance measurements recorded by the electrodes may be used to predict ice formation, quality of pulmonary vein occlusion, and lesion formation.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: June 11, 2024
    Assignee: Medtronic CryoCath LP
    Inventors: Boaz Avitall, Catherine R. Condie
  • Patent number: 12003127
    Abstract: A mobile phone cover is provided comprising: a holder 120, 1120, 2120, 3120 for receiving and retaining a mobile phone 108, the mobile phone comprising an energy supply; a portable charging device 106, 1106, 2106, 3106 having two or more charging stations 110, 1110, 2110, 3110, each charging station 110, 1110, 2110, 3110 being configured and arranged for receiving and retaining a rechargeable instrument 104, the rechargeable instrument 104 comprising an energy storage; the portable charging device 106, 1106, 2106, 3106 being further configured and arranged: to transfer energy, in use, from the energy supply of the mobile phone 108, placed in the holder, to the two or more charging stations 110, 1110, 2110, 3110; and to transfer energy, in use, from the charging stations 110, 1110, 2110, 3110 to the energy storage of the rechargeable instrument 104 placed in the respective charging station 110, 1110, 2110, 3110.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: June 4, 2024
    Assignee: Salvia BioElectronics B.V.
    Inventors: Daniël Willem Elisabeth Schobben, Hubert Cécile François Martens, Marjolein Wilhelmina Maria Schets
  • Patent number: 11978559
    Abstract: Systems and methods for identifying a condition of a user. A treatment apparatus is configured to be manipulated by the user for performing an exercise, and an interface is communicably coupled to the treatment apparatus. One or more sensors are configured to sense one or more characteristics of an anatomical structure of the user. A processing device and a memory is communicatively coupled to the processing device. The memory includes computer readable instructions, that when executed by the processing device, cause the processing device to: receive, from the sensors, one or more sensor inputs representative of the one or more of characteristics of the anatomical structures; calculate an infection probability of a disease based on the one or more characteristics of the anatomical structures; and output, to the interface, a representation of the infection probability.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: May 7, 2024
    Assignee: ROM Technologies, Inc.
    Inventors: Steven Mason, Daniel Posnack, Peter Arn, Wendy Para, S. Adam Hacking, Micheal Mueller, Joseph Guaneri, Jonathan Greene
  • Patent number: 11969587
    Abstract: The invention relates to a stent pump for intravascular, intraventricular or intraatrial placement inside the human heart comprising: —a preferably tubular housing having an inlet and an outlet, —an impeller, and —a stream former, wherein the impeller and optionally the stream former are arranged within the housing, characterized in that the stream former is arranged downstream of the impeller, and the housing, the stream former and/or the impeller are deployable from a first position, in which the housing, the stream former and/or the impeller are folded for being arranged within a delivery device, into a second, expanded position, in which the housing, the stream former and/or the impeller are deployed.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: April 30, 2024
    Assignee: Werner Mohl
    Inventor: Werner Mohl